Serum and glucocorticoid-induced kinase 1 (SGK1) belongs to the protein kinase "AGC" subfamily that participates in the pathophysiology of a variety of diseases including multiple fibrosis diseases, lung cancer and other types of malignancies 13-15, thus making SGK1 to be a potential prognostic indicator and therapeutic target. This evidence concerns the gene SGK1 and lung carcinoma.